Fibrotic Marker Multiplex ELISA Kits are launch

Fibrosis, defined by the excess deposition of extracellular matrix proteins due to dysregulated wound and connective tissue repair response. Fibrosis is associated with multiple chronic diseases including nonalcoholic fatty liver disease (NAFLD), chronic kidney diseases, idiopathic pulmonary fibrosis (IPF), cardiac fibrosis, and cystic fibrosis.

Studies reveal that extracellular factors including growth factors and cytokines mediate the progression of fibrosis. These factors are ideal markers to examine fibrosis. arigo is proud to introduce our Fibrotic Marker Multiplex ELISA Kits which allow a concurrent measurement of four fibrotic markers including IL-6, TNF-α, TGF-β1, and PDGF-BB. These kits make the complex quantification of multiple fibrotic markers easy and efficient. It is the best solution to study fibrosis in human, mice, or rats.

Benefits

● Concurrent measurement of 4 markers
    - IL-6,  TNF-α, TGF-β1,  PDGF-BB

● High sensitivity for quantification at pg/mL ranges
● Validated on serum, plasma, and cell culture supernatant
● Less sample volume and assay time required

ARG83353 for Human

ARG83349 for Mouse

ARG83356 for Rat

▶  Myofibroblast / Fibrosis Antibody Panel (ARG30346)